IMC Chicago’s ClearPoint Neuro CLPT Stock Holding History

IMC Chicago’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$588K	Sell	64,600 -19,700	-23%	-$249K	﹤0.01%	3860
2025 Q4	$1.15M	Buy	84,300 +33,800	+67%	+$627K	﹤0.01%	2865
2025 Q3	$1.1M	Buy	+50,500	New	+$595K	﹤0.01%	2643

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

IMC Chicago's CLPT Position: Q1 2026 in Review

IMC Chicago opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 47,543 shares worth $433K. The stake represents ﹤0.01% of the portfolio and ranks #4202 among its holdings.

118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

IMC Chicago held 47,543 shares of ClearPoint Neuro worth $433K as of Q1 2026.
ClearPoint Neuro was a new IMC Chicago position in Q1 2026.
ClearPoint Neuro made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4202 holding.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.